Thomas Yip analyst B. RILEY

Currently out of the existing stock ratings of Thomas Yip, 10 are a BUY (100%).

Thomas Yip

Work Performance Price Targets & Ratings Chart

Analyst Thomas Yip, currently employed at B. RILEY, carries an average stock price target met ratio of 33.33% that have a potential upside of 31.57% achieved within 255 days.

Thomas Yip’s has documented 20 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on OMER, Omeros at 17-Oct-2016.

Wall Street Analyst Thomas Yip

Analyst best performing recommendations are on GERN (GERON).
The best stock recommendation documented was for GERN (GERON) at 9/19/2016. The price target of $5 was fulfilled within 549 days with a profit of $3 (150%) receiving and performance score of 2.73.

Average potential price target upside

CERS Cerus GERN Geron OMER Omeros

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 01-May-2026

$4

$1.82 (83.49%)

5 months 22 days ago
(01-May-2026)

0/2 (0%)

$1.28 (47.06%)

Buy Since 03-Aug-2018

$5

$2.08 (71.23%)

$5

1 years 1 months 11 days ago
(12-Sep-2025)

0/5 (0%)

$3.77 (306.50%)

Buy Since 15-Jun-2020

$4

$1.82 (83.49%)

$4

1 years 2 months 12 days ago
(11-Aug-2025)

0/7 (0%)

$2.75 (220.00%)

Buy Since 08-Nov-2023

$4

$1.08 (36.99%)

$4

1 years 8 months 2 days ago
(21-Feb-2025)

1/3 (33.33%)

$2.35 (142.42%)

933

Buy Since 28-Aug-2019

$3

$0.08 (2.74%)

$6

2 years 6 days ago
(17-Oct-2024)

3/10 (30%)

$1.37 (84.05%)

368

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Thomas Yip?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?